Ultime notizie per Azenta (NASDAQ:AZTA) Azioni

Azenta

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

Azenta Inc

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Azenta</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/azta-stock-quote/"><strong>AZTA</strong></a></span>) just reported results for the second quarter of 2024.</p><ul><li>Azenta reported earnings per share of 5 cents. This was above the analyst estimate for EPS of 2 cents.</li><li>The company reported revenue of $159.13 million.</li><li>This was 0.43% worse than the analyst estimate for revenue of $159.82 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/azta-stock-earnings-azenta-for-q2-of-2024/">AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Green Thumb Industries (GTBIF – Research Report) and...

Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Azenta (AZTA)

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Robotics and automation go hand in hand. Inflationary pressures have been plaguing both consumers and business owners. This has lead to there now being several robotics stocks to sell. Over the last several years, not only did prices increase in certain commodities, but the U.S. labor market has also experienced high relative wage gains, particularly in the services sector. One way to businesses have chosen to protect themselves from inflation has been to embrace automation. The advent of advanced artificial intelligence technologies will also make robotics more useful and ubiquitous.</p>



<p>Investors who desire to make long-term bets on companies innovating with novel technologies have already been exploring robotics stocks. However, there are definitely some stocks in the robotics space to avoid. Below are three robotics stocks to sell.</p>



<h2>iRobot (IRBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/07/irbt1600-300x169.png" alt="In this photo illustration the iRobot Corporation (IRBT) logo seen displayed on a smartphone screen"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>iRobot</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/irbt-stock-quote/"><strong>IRBT</strong></a>) is a robotics company that focuses on delivering products to consumers. The firm&rsquo;s most notable product has been the Roomba vacuum, which made its debut way back in 2002. Since then, iRobot has been steadily developing and releasing a number of smart-home robotics devices to help consumers better maintain their homes. Despite experiencing years of solid double-digit growth prior to the global COVID-19 pandemic, iRobot has experienced its sales growth seriously contract in recent years.</p>



<p>Both fiscal years 2022 and 2023 saw iRobot&rsquo;s revenue declin by more than 24% on a year-over-year basis. In fact, last year marked the first year since 2017 that iRobot&rsquo;s annual revenue slipped under $1 billion. Declining consumer confidence and the high costs of novel technologies have largely disincentivized consumers from purchasing any new tech products. Moreover, the drop in iRobot&rsquo;s growth has been so bad that the company <a href="https://investor.irobot.com/news-releases/news-release-details/irobot-announces-operational-restructuring-plan-position-company">announced</a> a restructuring plan in January 2024 that included many operational costs cutting as well as CEO and Board Chairman Colin Angle stepping down after 33 years at the helm of iRobot.</p>



<p>Until consumer confidence reawakens, iRobot is going to remain one of the robotics stocks to sell.</p>



<h2>Rockwell Automation (ROK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/11/roku-stock-300x169.jpg" alt="Logo for Roku, Inc. (ROKU) displayed on a glass building"><div>Source: Michael Vi / Shutterstock</div></div><p><strong>Rockwell Automation</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/rok-stock-quote/"><strong>ROK</strong></a></span>) is an automation behemoth. The company works to drive efficiencies in a multitude of sub-verticals across the industrial sector through its three business segments: intelligent devices, software &amp; control and lifecycle services. The intelligent devices business unit sells a number of industrial components and sensor products to increase safety.</p>



<p>The company&rsquo;s diverse range of customers has not shielded it from all macroeconomic turmoil. In their first quarter <a href="https://app.koyfin.com/news/ts/eq-uyb4su/all/1868657176?sourceType=transcript">earnings call</a> for the Rockwell&rsquo;s fiscal year 2024, CEO Blake Moret noted discrete, automotive sales declined in the &ldquo;high single digits,&rdquo; which appears to be due to the headwinds facing the electric vehicle (EV) market. Rockwell also experienced sales declines in its e-commerce and warehousing end-market due to delayed modernization projects at logistics centers as consumer demand for goods remains low. These negative trends largely <a href="https://app.koyfin.com/news/ts/eq-uyb4su/all/1878888574?sourceType=transcript">continued</a> in the company&rsquo;s second quarter fiscal year 2024 report.   </p>



<p>Rockwell shares have declined 11.1% thus far this year as of the end of last Friday&rsquo;s trading session. If market volatility swings in the other direction, ROK stock can slip even further. </p>



<h2>Azenta (AZTA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/07/robotics-medical-1600-300x169.jpg" alt="robotic arms over medical bed symbolizing medical robotics. favorite robotics stocks to buy"><div>Source: shutterstock.com/MAD.vertise</div></div><p>The final entry on this list of robotics stocks to sell is <strong>Azenta</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/azta-stock-quote/"><strong>AZTA</strong></a></span>), a life sciences firm. The company develops sample exploration and management tools and solutions for laboratories. Azenta&rsquo;s automated technologies are also worth noting. The company has worked to develop automated sample storage systems, which &ldquo;not only ensure the integrity of [lab] samples but also improve inventory accuracy through meticulous documentation and digital audit trails.&rdquo; Coupled with these tools, laboratory specialists can also help themselves to Azenta&rsquo;s <a href="https://www.azenta.com/lab-automation-solutions">automated sample handling</a> tools. These not only improve efficiency at laboratories but also increase laboratory throughput.</p>



<p>Unfortunately, similar to the other entries on the list, the macroeconomic environment has also been harsh on Azenta&rsquo;s sales growth. Azenta&rsquo;s Q1 2024 earnings reported, ended in December, saw revenue decline 13% YOY, while the firm&rsquo;s second quarter earnings report only saw sales climb 7% YOY. For a company that is largely loss making, feeble revenue growth is something investors should definitely avoid. Shareholders are betting on companies like Azenta to reach breakeven as a soon as possible. However, it seems it will take Azenta some time.</p>



<p><em>On the date of publication, Tyrik Torres&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.</em></p>
<div><p>Tyrik Torres has been studying and participating in financial markets since he was in college, and he has particular passion for helping people understand complex systems. His areas of expertise are semiconductor and enterprise software equities. He has work experience in both investing (public and private markets) and investment banking.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/05/stock-market-crash-warning-dont-get-caught-holding-these-3-robotics-stocks/">Stock Market Crash Warning: Don&#8217;t Get Caught Holding These 3 Robotics Stocks</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks

Azenta Non-GAAP EPS of $0.16 beats by $0.09, revenue of $173M beats by $7.35M

Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Azenta</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/azta-stock-quote/"><strong>AZTA</strong></a></span>) just reported results for the third quarter of 2024.</p><ul><li>Azenta reported earnings per share of 16 cents. This was above the analyst estimate for EPS of 8 cents.</li><li>The company reported revenue of $172.81 million.</li><li>This was 4.15% better than the analyst estimate for revenue of $165.92 million.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><p>The post <a href="https://investorplace.com/earning-results/2024/08/azta-stock-earnings-azenta-for-q3-of-2024/">AZTA Stock Earnings: Azenta Beats EPS, Beats Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

AZTA Stock Earnings: Azenta Beats EPS, Beats Revenue for Q3 2024

In a report released today, David Saxon from Needham reiterated a Buy rating on Azenta (AZTA – Research Report), with a price target of $69.00. Dav...

Buy Rating Justified by Azenta's Strong Q3 Performance and Growth Potential

Update on Oppenheimer's buy vs. sell SMID ideas from each of the sectors

The latest update is out from Azenta (AZTA). Azenta, Inc. has announced the appointment of John Marotta as the new President and Chief Executive Of...

John Marotta Named Azenta's New President and CEO

Azenta: Life Science Play Is Not Coming To Life

ALRM

AVNT

AZTA

BOOT

CARG

CARS

GTBIF

IIPR

IRBT

JACK

MNDY

POST

SMPL

TREE

UTHR

XLRE

Press Releases

Azenta Announces CEO Succession Plan

Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK

Azenta to Participate in the Jefferies Global Healthcare Conference

Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research

News

Contracts

FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study

Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast

Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Earnings

Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event

Comments

Azenta

Notizie

Ultime notizie per Azenta (NASDAQ:AZTA) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO